New York State Common Retirement Fund’s CorMedix CRMD Stock Holding History

New York State Common Retirement Fund’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.91M	Sell	242,785 -54,678	-18%	-$432K	﹤0.01%	1479
2026 Q1	$2.02M	Sell	297,463 -23,534	-7%	-$174K	﹤0.01%	1382
2025 Q4	$3.73M	Buy	320,997 +23,534	+8%	+$260K	0.01%	1145
2025 Q3	$3.46M	Hold	297,463	–	–	﹤0.01%	1227
2025 Q2	$3.66M	Buy	297,463 +143,700	+93%	+$1.59M	﹤0.01%	1194
2025 Q1	$947K	Sell	153,763 -13,486	-8%	-$140K	﹤0.01%	1651
2024 Q4	$1.35M	Buy	167,249 +156,086	+1,398%	+$1.56M	﹤0.01%	1562
2024 Q3	$90.2K	Sell	11,163 -6,900	-38%	-$37.3K	﹤0.01%	2636
2024 Q2	$78.2K	Buy	18,063 +32	+0.2%	+$163	﹤0.01%	2962
2024 Q1	$76.5K	Hold	18,031	–	–	﹤0.01%	2841
2023 Q4	$67.8K	Sell	18,031 -119	-0.7%	-$410	﹤0.01%	2900
2023 Q3	$67.2K	Buy	18,150 +550	+3%	+$2.19K	﹤0.01%	2912
2023 Q2	$69.8K	Buy	+17,600	New	+$87.1K	﹤0.01%	3051
2022 Q3	–	Sell	-268	Closed	-$1K	–	3306
2022 Q2	$1K	Sell	268 -23,250	-99%	-$86.4K	﹤0.01%	3333
2022 Q1	$129K	Hold	23,518	–	–	﹤0.01%	2964
2021 Q4	$107K	Sell	23,518 -63	-0.3%	-$313	﹤0.01%	3059
2021 Q3	$110K	Buy	23,581 +117	+0.5%	+$681	﹤0.01%	3108
2021 Q2	$161K	Buy	23,464 +264	+1%	+$2.1K	﹤0.01%	3115
2021 Q1	$232K	Buy	23,200 +1,800	+8%	+$18.9K	﹤0.01%	2780
2020 Q4	$159K	Buy	21,400 +6,800	+47%	+$46.2K	﹤0.01%	2833
2020 Q3	$88K	Hold	14,600	–	–	﹤0.01%	2985
2020 Q2	$92K	Hold	14,600	–	–	﹤0.01%	3014
2020 Q1	$52K	Hold	14,600	–	–	﹤0.01%	2976
2019 Q4	$106K	Sell	14,600 -9,500	-39%	-$58.1K	﹤0.01%	2987
2019 Q3	$154K	Hold	24,100	–	–	﹤0.01%	2886
2019 Q2	$216K	Buy	+24,100	New	+$189K	﹤0.01%	2772
2016 Q2	–	Sell	-5,660	Closed	-$75K	–	3193
2016 Q1	$75K	Hold	5,660	–	–	﹤0.01%	2992
2015 Q4	$57K	Hold	5,660	–	–	﹤0.01%	3096
2015 Q3	$56K	Buy	5,660 +1,588	+39%	+$24.5K	﹤0.01%	3107
2015 Q2	$79K	Buy	+4,072	New	+$140K	﹤0.01%	3151

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

New York State Common Retirement Fund's CRMD Position: Q2 2026 in Review

New York State Common Retirement Fund reduced its CorMedix (CRMD) stake by 18% in Q2 2026, selling an estimated $432K and leaving 242,785 shares worth $1.91M. The position accounts for ﹤0.01% of the portfolio, ranked #1479.

New York State Common Retirement Fund first reported a position in CRMD in Q2 2015 and has held it in 30 quarters since. The position peaked at $3.73M in Q4 2025. 193 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

New York State Common Retirement Fund held 242,785 shares of CorMedix worth $1.91M as of Q2 2026.
New York State Common Retirement Fund sold 54,678 CorMedix shares in Q2 2026, an estimated $432K.
CorMedix made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1479 holding.
New York State Common Retirement Fund first reported a position in CorMedix in Q2 2015 and has held it in 30 quarters since.
New York State Common Retirement Fund's CorMedix position peaked at $3.73M in Q4 2025.
193 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.